Jitongning tablets for active spondyloarthritis
Part of Bones, joints & muscles clinical trials.
This trial tests a Chinese herbal tablet called Jitongning against a placebo to see if it can improve overall symptoms in people with active axial osteoarthritis. You may be eligible if your arthritis is active, you have a specific genetic marker (HLA-B27 positive), and your inflammation levels are high.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have axial osteoarthritis (a type of arthritis mainly affecting the spine and sacroiliac joints) that is currently active
- Your condition matches the traditional Chinese medicine pattern called 'kidney yang deficiency with blood stasis' (common symptoms: cold lower back pain, weak knees, dark tongue)
- Your imaging shows grade I to II sacroiliitis (mild to moderate joint inflammation on CT scan)
- You test positive for the genetic marker HLA-B27
- You have elevated inflammation markers in your blood (CRP or ESR) measured recently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
This trial is for people with ankylosing spondylitis (a type of arthritis that affects the spine) who are otherwise healthy. It may test a treatment to see if it helps control symptoms, whether your disease is active or stable.
This study tests whether combining two types of immune-blocking drugs (an IL-17 inhibitor and a TNF inhibitor) works better than either alone for treating ankylosing spondylitis. It is for people whose symptoms are not well controlled with NSAIDs.
This trial tests whether stem cells from umbilical cord can reduce pain and stiffness in people with ankylosing spondylitis (a disease causing spinal inflammation). You may qualify if you have active AS that hasn't responded well to standard treatments.
This study tests a new medication called vilamakitug for people with active axial spondyloarthritis. It aims to see if the drug can reduce pain and inflammation better than a placebo (a dummy treatment).
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.